BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krementsov DN, Wall EH, Martin RA, Subramanian M, Noubade R, Del Rio R, Mawe GM, Bond JP, Poynter ME, Blankenhorn EP, Teuscher C. Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility. PLoS One 2013;8:e62743. [PMID: 23894272 DOI: 10.1371/journal.pone.0062743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Kyriakidis K, Zampeli E, Palaiologou M, Tiniakos D, Tiligada E. Histamine H3 and H4 receptor ligands modify vascular histamine levels in normal and arthritic large blood vessels in vivo. Inflammation 2015;38:949-58. [PMID: 25359709 DOI: 10.1007/s10753-014-0057-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Micallef S, Sasse A. Genetic Polymorphisms in the Histamine Receptor Family. In: Blandina P, Passani MB, editors. Histamine Receptors. Cham: Springer International Publishing; 2016. pp. 51-74. [DOI: 10.1007/978-3-319-40308-3_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Noguchi K, Ishida J, Kim JD, Muromachi N, Kako K, Mizukami H, Lu W, Ishimaru T, Kawasaki S, Kaneko S, Usui J, Ohtsu H, Yamagata K, Fukamizu A. Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming. Proc Natl Acad Sci U S A 2020;117:3150-6. [PMID: 31992639 DOI: 10.1073/pnas.1909124117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Khanfar MA, Reiner D, Hagenow S, Stark H. Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands. Bioorg Med Chem 2018;26:4034-46. [PMID: 29960729 DOI: 10.1016/j.bmc.2018.06.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev 2015;67:601-55. [PMID: 26084539 DOI: 10.1124/pr.114.010249] [Cited by in Crossref: 263] [Cited by in F6Publishing: 240] [Article Influence: 43.8] [Reference Citation Analysis]
6 Moriguchi T, Takai J. Histamine and histidine decarboxylase: Immunomodulatory functions and regulatory mechanisms. Genes Cells 2020;25:443-9. [PMID: 32394600 DOI: 10.1111/gtc.12774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Eiriz MF, Valero J, Malva JO, Bernardino L. New insights into the role of histamine in subventricular zone-olfactory bulb neurogenesis. Front Neurosci 2014;8:142. [PMID: 24982610 DOI: 10.3389/fnins.2014.00142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
8 Auberson YP, Troxler T, Zhang X, Yang CR, Fendt M, Feuerbach D, Liu Y, Lagu B, Lerchner A, Perrone M, Lei L, Zhang C, Wang C, Wang T, Bock MG. Ergoline-Derived Inverse Agonists of the Human H3 Receptor for the Treatment of Narcolepsy. ChemMedChem 2014. [DOI: 10.1002/cmdc.201402055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Zhao X, Liu R, Chen Y, Hettinghouse A, Liu C. Cytosolic Phospholipase A2 Is Required for Fexofenadine's Therapeutic Effects against Inflammatory Bowel Disease in Mice. Int J Mol Sci 2021;22:11155. [PMID: 34681815 DOI: 10.3390/ijms222011155] [Reference Citation Analysis]
10 Rangon CM, Schang AL, Van Steenwinckel J, Schwendimann L, Lebon S, Fu T, Chen L, Beneton V, Journiac N, Young-Ten P, Bourgeois T, Maze J, Matrot B, Baburamani AA, Supramaniam V, Mallard C, Trottet L, Edwards AD, Hagberg H, Fleiss B, Li J, Chuang TT, Gressens P. Myelination induction by a histamine H3 receptor antagonist in a mouse model of preterm white matter injury. Brain Behav Immun 2018;74:265-76. [PMID: 30218783 DOI: 10.1016/j.bbi.2018.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Molenhuis RT, Hutten L, Kas MJH. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice. Pharmacol Biochem Behav 2021;212:173304. [PMID: 34856309 DOI: 10.1016/j.pbb.2021.173304] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Łażewska D, Kieć-Kononowicz K. Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017). Expert Opin Ther Pat 2018;28:175-96. [PMID: 29334795 DOI: 10.1080/13543776.2018.1424135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]